Development of Criteria for Evaluating Clinical Response in Thyroid Eye Disease Using a Modified Delphi Technique
Open Access
- 14 September 2009
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 127 (9) , 1155-1160
Abstract
Graves disease is a multisystem autoimmune disorder targeting the thyroid, orbit, and skin. The orbital disease runs a biphasic course. The initial active phase can be dominated by inflammation of orbital soft tissues and expansion of fat accompanied or followed by progressive fibrosis and its attendant abnormalities of eye motility. Thyroid eye disease (TED), also referred to as thyroid-associated ophthalmopathy and Graves orbitopathy, encompasses the orbital and periorbital manifestations of Graves disease and causes substantial morbidity and reduced quality of life.1-4Keywords
This publication has 47 references indexed in Scilit:
- A Single Course of Anti-CD3 Monoclonal Antibody hOKT3γ1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 DiabetesDiabetes, 2005
- Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritisExpert Opinion on Biological Therapy, 2004
- Transitional care for adolescents with juvenile idiopathic arthritis: a Delphi studyRheumatology, 2004
- Disease-Specific Assessment of Quality of Life after Decompression Surgery for Graves' OphthalmopathyEuropean Journal of Ophthalmology, 2004
- Assessing quality of life in Australian patients with Graves' ophthalmopathyBritish Journal of Ophthalmology, 2004
- International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitisAnnals of the Rheumatic Diseases, 2003
- Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experienceEuropean Journal of Endocrinology, 2003
- Psychosocial Factors in Subjects with Thyroid-Associated OphthalmopathyThyroid®, 2002
- Rheumatoid arthritis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise.1991
- Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise.1991